Inhibition of Cell Growth Through Inactivation of Eukaryotic Translation Initiation Factor 5A (eIF5A) by Deoxyspergualin

Overview

Journal Biochem J

Specialty Biochemistry

Date 2002 Apr 20

PMID 11964177

Citations 12

Authors

Kazuhiro Nishimura

Yuji Ohki

Tomomi Fukuchi-Shimogori

Kaori Sakata

Kan Saiga

Takanobu Beppu

Akira Shirahata

Keiko Kashiwagi

Kazuei Igarashi

Affiliations

Soon will be listed here.

Abstract

The mechanism of inhibition of cell growth by deoxyspergualin was studied using mouse mammary carcinoma FM3A cells. Results of studies using deoxyspergualin analogues showed that both the guanidinoheptanate amide and glyoxyspermidine moieties of deoxyspergualin were necessary to cause inhibition of cell growth. When deoxyspergualin was added to the medium, there was a strong inhibition of cell growth and formation of active eukaryotic translation initiation factor 5A (eIF5A) at the third day of culture. There was also a marked decrease in cellular putrescine content and a small decrease in spermidine content. Accumulation of decapped mRNA, which is typically associated with eIF5A deficiency in yeast, was also observed. The inhibition of cell growth and the formation of active eIF5A was not reversed by addition of spermidine. The activity of deoxyhypusine synthase, the first enzyme in the formation of active eIF5A, was inhibited by deoxyspergualin in a cell-free system. These results, taken together, indicate that inhibition of active eIF5A formation is strongly involved in the inhibition of cell growth by deoxyspergualin.

Citing Articles

Development of a reliable, sensitive, and convenient assay for the discovery of new eIF5A hypusination inhibitors.

Benaceur O, Ferreira Montenegro P, Kahi M, Fontaine-Vive F, Mazure N, Mehiri M PLoS One. 2025; 20(2):e0308049.

PMID: 39937781 PMC: 11819603. DOI: 10.1371/journal.pone.0308049.

An Undefined Interaction between Polyamines and Heat Shock Proteins Leads to Cellular Protection in and Proliferating Cells in Various Organisms.

Makhoba X, Ragno R, Kaiser A, Agostinelli E Molecules. 2023; 28(4).

PMID: 36838674 PMC: 9958663. DOI: 10.3390/molecules28041686.

Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression.

Zhou J, Pang J, Tripathi M, Ho J, Widjaja A, Shekeran S Nat Commun. 2022; 13(1):5202.

PMID: 36057633 PMC: 9440896. DOI: 10.1038/s41467-022-32788-x.

The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles.

Tauc M, Cougnon M, Carcy R, Melis N, Hauet T, Pellerin L Cell Biosci. 2021; 11(1):219.

PMID: 34952646 PMC: 8705083. DOI: 10.1186/s13578-021-00733-y.

New Series of Potent Allosteric Inhibitors of Deoxyhypusine Synthase.

Tanaka Y, Kurasawa O, Yokota A, Klein M, Saito B, Matsumoto S ACS Med Chem Lett. 2021; 11(8):1645-1652.

PMID: 34345355 PMC: 8323115. DOI: 10.1021/acsmedchemlett.0c00331.

References

Nielsen P, Manchester K, Towbin H, Gordon J, Thomas G . The phosphorylation of ribosomal protein S6 in rat tissues following cycloheximide injection, in diabetes, and after denervation of diaphragm. A simple immunological determination of the extent of S6 phosphorylation on protein blots. J Biol Chem. 1982; 257(20):12316-21. View

Umezawa H, Kondo S, Iinuma H, Kunimoto S, Ikeda Y, Iwasawa H . Structure of an antitumor antibiotic, spergualin. J Antibiot (Tokyo). 1981; 34(12):1622-4. DOI: 10.7164/antibiotics.34.1622. View

Umezawa H, Ishizuka M, Takeuchi T, Abe F, Nemoto K, Shibuya K . Suppression of tissue graft rejection by spergualin. J Antibiot (Tokyo). 1985; 38(2):283-4. DOI: 10.7164/antibiotics.38.283. View

Umeda Y, Moriguchi M, Kuroda H, Nakamura T, Iinuma H, Takeuchi T . Synthesis and antitumor activity of spergualin analogues. I. Chemical modification of 7-guanidino-3-hydroxyacyl moiety. J Antibiot (Tokyo). 1985; 38(7):886-98. DOI: 10.7164/antibiotics.38.886. View

Pera P, Kramer D, Sufrin J, Porter C . Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines. Cancer Res. 1986; 46(3):1148-54. View

Igarashi K, Kashiwagi K, Hamasaki H, Miura A, Kakegawa T, Hirose S . Formation of a compensatory polyamine by Escherichia coli polyamine-requiring mutants during growth in the absence of polyamines. J Bacteriol. 1986; 166(1):128-34. PMC: 214567. DOI: 10.1128/jb.166.1.128-134.1986. View

Plowman J, Harrison Jr S, Trader M, Griswold Jr D, Chadwick M, McComish M . Preclinical antitumor activity and pharmacological properties of deoxyspergualin. Cancer Res. 1987; 47(3):685-9. View

Umeda Y, Moriguchi M, Kuroda H, Nakamura T, Fujii A, Iinuma H . Synthesis and antitumor activity of spergualin analogues. II. Chemical modification of the spermidine moiety. J Antibiot (Tokyo). 1987; 40(9):1303-15. DOI: 10.7164/antibiotics.40.1303. View

Kakinuma Y, SAKAMAKI Y, Ito K, Cragoe Jr E, Igarashi K . Relationship among activation of the Na+/H+ antiporter, ornithine decarboxylase induction, and DNA synthesis. Arch Biochem Biophys. 1987; 259(1):171-8. DOI: 10.1016/0003-9861(87)90483-8. View

10.

Makino M, Fujiwara M, Watanabe H, Aoyagi T, Umezawa H . Immunosuppressive activities of deoxyspergualin. II. The effect on the antibody responses. Immunopharmacology. 1987; 14(2):115-21. DOI: 10.1016/0162-3109(87)90036-1. View

11.

Smit-McBride Z, Dever T, Hershey J, Merrick W . Sequence determination and cDNA cloning of eukaryotic initiation factor 4D, the hypusine-containing protein. J Biol Chem. 1989; 264(3):1578-83. View

12.

Fujii H, Takada T, Nemoto K, Abe F, Takeuchi T . Stability and immunosuppressive activity of deoxyspergualin in comparison with deoxymethylspergualin. Transplant Proc. 1989; 21(3):3471-3. View

13.

Pai L, Fitzgerald D, Tepper M, Schacter B, Spitalny G, Pastan I . Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice. Cancer Res. 1990; 50(24):7750-3. View

14.

Hibasami H, Tsukada T, Suzuki R, Takano K, Takaji S, Takeuchi T . 15-Deoxyspergualin, an antiproliferative agent for human and mouse leukemia cells shows inhibitory effects on the synthetic pathway of polyamines. Anticancer Res. 1991; 11(1):325-30. View

15.

SCHNIER J, Schwelberger H, Smit-McBride Z, Kang H, Hershey J . Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae. Mol Cell Biol. 1991; 11(6):3105-14. PMC: 360154. DOI: 10.1128/mcb.11.6.3105-3114.1991. View

16.

Hiratsuka M, Kuramochi H, Takahashi K, Takeuchi T, Oshimura M . Cytostatic effect of deoxyspergualin on a murine leukemia cell line L1210. Jpn J Cancer Res. 1991; 82(10):1065-8. PMC: 5918251. DOI: 10.1111/j.1349-7006.1991.tb01758.x. View

17.

Nadler S, Tepper M, Schacter B, Mazzucco C . Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science. 1992; 258(5081):484-6. DOI: 10.1126/science.1411548. View

18.

Kameji T, Hayashi S, Hoshino K, Kakinuma Y, Igarashi K . Multiple regulation of ornithine decarboxylase in enzyme-overproducing cells. Biochem J. 1993; 289 ( Pt 2):581-6. PMC: 1132208. DOI: 10.1042/bj2890581. View

19.

Jakus J, Wolff E, Park M, Folk J . Features of the spermidine-binding site of deoxyhypusine synthase as derived from inhibition studies. Effective inhibition by bis- and mono-guanylated diamines and polyamines. J Biol Chem. 1993; 268(18):13151-9. View

20.

Suzuki T, Sadakata Y, Kashiwagi K, Hoshino K, Kakinuma Y, Shirahata A . Overproduction of S-adenosylmethionine decarboxylase in ethylglyoxal-bis(guanylhydrazone)-resistant mouse FM3A cells. Eur J Biochem. 1993; 215(2):247-53. DOI: 10.1111/j.1432-1033.1993.tb18029.x. View